J&J gets FDA approval for smaller Cypher stent

09/21/2009 | NYTimes.com

Johnson & Johnson received FDA approval for a 2.25-millimeter version of its Cypher drug-eluting stent, designed to treat smaller blood vessels. The agency granted approval after a study showed that the device was more effective than bare-metal stents in keeping small blood vessels from reclogging.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN